DYNE THERAPEUTICS INC. - COMMON STOCK
32.58
04-10月-24 14:59:59
15 分の遅延
株式
-0.97
-2.89%
本日の幅
32.39 - 34.00
ISIN
N/A
ソース
NASDAQ
-
Dyne Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights
02 5 2022 15:05:01 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Highlights
10 3 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Appoints Carlo Incerti, M.D., to its Board of Directors
03 3 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
18 1 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
05 1 2022 06:30:00 提供 Nasdaq GlobeNewswire
-
02 12 2021 07:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights
04 11 2021 06:30:01 提供 Nasdaq GlobeNewswire
-
13 10 2021 06:45:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Host Virtual Research and Development Day on Wednesday, October 13, 2021
28 9 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Chardan’s Virtual 5th Annual Genetic Medicines Conference
27 9 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights
05 8 2021 06:30:01 提供 Nasdaq GlobeNewswire
-
25 6 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Announces Chief Scientific Officer Transition
02 6 2021 15:05:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics to Present at Jefferies Virtual Healthcare Conference
26 5 2021 06:30:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights
06 5 2021 06:29:00 提供 Nasdaq GlobeNewswire
-
Dyne Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
04 3 2021 06:35:00 提供 Nasdaq GlobeNewswire